With quinine-based drugs, traditionally sought to treat malaria, failing to contain the disease anymore, scientists of the Central Institute of Medicinal and Aromatic Plants (cimap), based in Lucknow, have now developed a new drug in their war against the disease.
Certain strains of the malarial parasite have developed resistance to the quinine-based drugs. The new drug involves the conversion of arteminisinic acid into artemisinin, till now deemed unachievable in India; the drug, while available in China and Burma, was not available here.
Artemisinin is an anti-malarial compound -- active against the malarial parasite -- derived from the plant Artemisia annua, which is now being cultivated in the Kashmir valley. It has also been adapted to grow in the plains. A new liquid extraction technology developed by cimap led to the isolation of the artemisinin present in the flowers and leaves of the plant in low concentrations.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.